Global Convalescent Plasma Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Convalescent Plasma Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The Global Info Research report includes an overview of the development of the Convalescent Plasma Therapy industry chain, the market status of Prophylaxis (IgM, IgG), Treatment (IgM, IgG), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Convalescent Plasma Therapy.

Regionally, the report analyzes the Convalescent Plasma Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Convalescent Plasma Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Convalescent Plasma Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Convalescent Plasma Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., IgM, IgG).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Convalescent Plasma Therapy market.

Regional Analysis: The report involves examining the Convalescent Plasma Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Convalescent Plasma Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Convalescent Plasma Therapy:
Company Analysis: Report covers individual Convalescent Plasma Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Convalescent Plasma Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Prophylaxis, Treatment).

Technology Analysis: Report covers specific technologies relevant to Convalescent Plasma Therapy. It assesses the current state, advancements, and potential future developments in Convalescent Plasma Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Convalescent Plasma Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Convalescent Plasma Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    IgM
    IgG
    IgA

Market segment by Application
    Prophylaxis
    Treatment

Market segment by players, this report covers
    Bio Farma
    Grifols
    Hilton Pharma
    Biotest
    BPL
    LFB
    Octapharma
    CSL Behring
    Takeda Pharmaceutical Company Limited
    Orthosera Kft

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Convalescent Plasma Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Convalescent Plasma Therapy, with revenue, gross margin and global market share of Convalescent Plasma Therapy from 2019 to 2024.
Chapter 3, the Convalescent Plasma Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Convalescent Plasma Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Convalescent Plasma Therapy.
Chapter 13, to describe Convalescent Plasma Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Convalescent Plasma Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Convalescent Plasma Therapy by Type
        1.3.1 Overview: Global Convalescent Plasma Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Convalescent Plasma Therapy Consumption Value Market Share by Type in 2023
        1.3.3 IgM
        1.3.4 IgG
        1.3.5 IgA
    1.4 Global Convalescent Plasma Therapy Market by Application
        1.4.1 Overview: Global Convalescent Plasma Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Prophylaxis
        1.4.3 Treatment
    1.5 Global Convalescent Plasma Therapy Market Size & Forecast
    1.6 Global Convalescent Plasma Therapy Market Size and Forecast by Region
        1.6.1 Global Convalescent Plasma Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Convalescent Plasma Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Convalescent Plasma Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Convalescent Plasma Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Convalescent Plasma Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Convalescent Plasma Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Convalescent Plasma Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Bio Farma
        2.1.1 Bio Farma Details
        2.1.2 Bio Farma Major Business
        2.1.3 Bio Farma Convalescent Plasma Therapy Product and Solutions
        2.1.4 Bio Farma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bio Farma Recent Developments and Future Plans
    2.2 Grifols
        2.2.1 Grifols Details
        2.2.2 Grifols Major Business
        2.2.3 Grifols Convalescent Plasma Therapy Product and Solutions
        2.2.4 Grifols Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Grifols Recent Developments and Future Plans
    2.3 Hilton Pharma
        2.3.1 Hilton Pharma Details
        2.3.2 Hilton Pharma Major Business
        2.3.3 Hilton Pharma Convalescent Plasma Therapy Product and Solutions
        2.3.4 Hilton Pharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Hilton Pharma Recent Developments and Future Plans
    2.4 Biotest
        2.4.1 Biotest Details
        2.4.2 Biotest Major Business
        2.4.3 Biotest Convalescent Plasma Therapy Product and Solutions
        2.4.4 Biotest Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Biotest Recent Developments and Future Plans
    2.5 BPL
        2.5.1 BPL Details
        2.5.2 BPL Major Business
        2.5.3 BPL Convalescent Plasma Therapy Product and Solutions
        2.5.4 BPL Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 BPL Recent Developments and Future Plans
    2.6 LFB
        2.6.1 LFB Details
        2.6.2 LFB Major Business
        2.6.3 LFB Convalescent Plasma Therapy Product and Solutions
        2.6.4 LFB Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 LFB Recent Developments and Future Plans
    2.7 Octapharma
        2.7.1 Octapharma Details
        2.7.2 Octapharma Major Business
        2.7.3 Octapharma Convalescent Plasma Therapy Product and Solutions
        2.7.4 Octapharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Octapharma Recent Developments and Future Plans
    2.8 CSL Behring
        2.8.1 CSL Behring Details
        2.8.2 CSL Behring Major Business
        2.8.3 CSL Behring Convalescent Plasma Therapy Product and Solutions
        2.8.4 CSL Behring Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 CSL Behring Recent Developments and Future Plans
    2.9 Takeda Pharmaceutical Company Limited
        2.9.1 Takeda Pharmaceutical Company Limited Details
        2.9.2 Takeda Pharmaceutical Company Limited Major Business
        2.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product and Solutions
        2.9.4 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
    2.10 Orthosera Kft
        2.10.1 Orthosera Kft Details
        2.10.2 Orthosera Kft Major Business
        2.10.3 Orthosera Kft Convalescent Plasma Therapy Product and Solutions
        2.10.4 Orthosera Kft Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Orthosera Kft Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Convalescent Plasma Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Convalescent Plasma Therapy by Company Revenue
        3.2.2 Top 3 Convalescent Plasma Therapy Players Market Share in 2023
        3.2.3 Top 6 Convalescent Plasma Therapy Players Market Share in 2023
    3.3 Convalescent Plasma Therapy Market: Overall Company Footprint Analysis
        3.3.1 Convalescent Plasma Therapy Market: Region Footprint
        3.3.2 Convalescent Plasma Therapy Market: Company Product Type Footprint
        3.3.3 Convalescent Plasma Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Convalescent Plasma Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Convalescent Plasma Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Convalescent Plasma Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Convalescent Plasma Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Convalescent Plasma Therapy Consumption Value by Type (2019-2030)
    6.2 North America Convalescent Plasma Therapy Consumption Value by Application (2019-2030)
    6.3 North America Convalescent Plasma Therapy Market Size by Country
        6.3.1 North America Convalescent Plasma Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Convalescent Plasma Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Convalescent Plasma Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Convalescent Plasma Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Convalescent Plasma Therapy Market Size by Country
        7.3.1 Europe Convalescent Plasma Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Convalescent Plasma Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Convalescent Plasma Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Convalescent Plasma Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Convalescent Plasma Therapy Market Size by Region
        8.3.1 Asia-Pacific Convalescent Plasma Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Convalescent Plasma Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Convalescent Plasma Therapy Consumption Value by Type (2019-2030)
    9.2 South America Convalescent Plasma Therapy Consumption Value by Application (2019-2030)
    9.3 South America Convalescent Plasma Therapy Market Size by Country
        9.3.1 South America Convalescent Plasma Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Convalescent Plasma Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Convalescent Plasma Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Convalescent Plasma Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Convalescent Plasma Therapy Market Size by Country
        10.3.1 Middle East & Africa Convalescent Plasma Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Convalescent Plasma Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Convalescent Plasma Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Convalescent Plasma Therapy Market Drivers
    11.2 Convalescent Plasma Therapy Market Restraints
    11.3 Convalescent Plasma Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Convalescent Plasma Therapy Industry Chain
    12.2 Convalescent Plasma Therapy Upstream Analysis
    12.3 Convalescent Plasma Therapy Midstream Analysis
    12.4 Convalescent Plasma Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Convalescent Plasma Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Convalescent Plasma Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Convalescent Plasma Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Convalescent Plasma Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Bio Farma Company Information, Head Office, and Major Competitors
    Table 6. Bio Farma Major Business
    Table 7. Bio Farma Convalescent Plasma Therapy Product and Solutions
    Table 8. Bio Farma Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Bio Farma Recent Developments and Future Plans
    Table 10. Grifols Company Information, Head Office, and Major Competitors
    Table 11. Grifols Major Business
    Table 12. Grifols Convalescent Plasma Therapy Product and Solutions
    Table 13. Grifols Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Grifols Recent Developments and Future Plans
    Table 15. Hilton Pharma Company Information, Head Office, and Major Competitors
    Table 16. Hilton Pharma Major Business
    Table 17. Hilton Pharma Convalescent Plasma Therapy Product and Solutions
    Table 18. Hilton Pharma Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Hilton Pharma Recent Developments and Future Plans
    Table 20. Biotest Company Information, Head Office, and Major Competitors
    Table 21. Biotest Major Business
    Table 22. Biotest Convalescent Plasma Therapy Product and Solutions
    Table 23. Biotest Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Biotest Recent Developments and Future Plans
    Table 25. BPL Company Information, Head Office, and Major Competitors
    Table 26. BPL Major Business
    Table 27. BPL Convalescent Plasma Therapy Product and Solutions
    Table 28. BPL Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. BPL Recent Developments and Future Plans
    Table 30. LFB Company Information, Head Office, and Major Competitors
    Table 31. LFB Major Business
    Table 32. LFB Convalescent Plasma Therapy Product and Solutions
    Table 33. LFB Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. LFB Recent Developments and Future Plans
    Table 35. Octapharma Company Information, Head Office, and Major Competitors
    Table 36. Octapharma Major Business
    Table 37. Octapharma Convalescent Plasma Therapy Product and Solutions
    Table 38. Octapharma Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Octapharma Recent Developments and Future Plans
    Table 40. CSL Behring Company Information, Head Office, and Major Competitors
    Table 41. CSL Behring Major Business
    Table 42. CSL Behring Convalescent Plasma Therapy Product and Solutions
    Table 43. CSL Behring Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. CSL Behring Recent Developments and Future Plans
    Table 45. Takeda Pharmaceutical Company Limited Company Information, Head Office, and Major Competitors
    Table 46. Takeda Pharmaceutical Company Limited Major Business
    Table 47. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product and Solutions
    Table 48. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
    Table 50. Orthosera Kft Company Information, Head Office, and Major Competitors
    Table 51. Orthosera Kft Major Business
    Table 52. Orthosera Kft Convalescent Plasma Therapy Product and Solutions
    Table 53. Orthosera Kft Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Orthosera Kft Recent Developments and Future Plans
    Table 55. Global Convalescent Plasma Therapy Revenue (USD Million) by Players (2019-2024)
    Table 56. Global Convalescent Plasma Therapy Revenue Share by Players (2019-2024)
    Table 57. Breakdown of Convalescent Plasma Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Convalescent Plasma Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key Convalescent Plasma Therapy Players
    Table 60. Convalescent Plasma Therapy Market: Company Product Type Footprint
    Table 61. Convalescent Plasma Therapy Market: Company Product Application Footprint
    Table 62. Convalescent Plasma Therapy New Market Entrants and Barriers to Market Entry
    Table 63. Convalescent Plasma Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Convalescent Plasma Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global Convalescent Plasma Therapy Consumption Value Share by Type (2019-2024)
    Table 66. Global Convalescent Plasma Therapy Consumption Value Forecast by Type (2025-2030)
    Table 67. Global Convalescent Plasma Therapy Consumption Value by Application (2019-2024)
    Table 68. Global Convalescent Plasma Therapy Consumption Value Forecast by Application (2025-2030)
    Table 69. North America Convalescent Plasma Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America Convalescent Plasma Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America Convalescent Plasma Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. North America Convalescent Plasma Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. North America Convalescent Plasma Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America Convalescent Plasma Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe Convalescent Plasma Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe Convalescent Plasma Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe Convalescent Plasma Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 78. Europe Convalescent Plasma Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 79. Europe Convalescent Plasma Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Convalescent Plasma Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Convalescent Plasma Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific Convalescent Plasma Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific Convalescent Plasma Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 84. Asia-Pacific Convalescent Plasma Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 85. Asia-Pacific Convalescent Plasma Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific Convalescent Plasma Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America Convalescent Plasma Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America Convalescent Plasma Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America Convalescent Plasma Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 90. South America Convalescent Plasma Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 91. South America Convalescent Plasma Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America Convalescent Plasma Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa Convalescent Plasma Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Convalescent Plasma Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa Convalescent Plasma Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 96. Middle East & Africa Convalescent Plasma Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Convalescent Plasma Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa Convalescent Plasma Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. Convalescent Plasma Therapy Raw Material
    Table 100. Key Suppliers of Convalescent Plasma Therapy Raw Materials
List of Figures
    Figure 1. Convalescent Plasma Therapy Picture
    Figure 2. Global Convalescent Plasma Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Convalescent Plasma Therapy Consumption Value Market Share by Type in 2023
    Figure 4. IgM
    Figure 5. IgG
    Figure 6. IgA
    Figure 7. Global Convalescent Plasma Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Convalescent Plasma Therapy Consumption Value Market Share by Application in 2023
    Figure 9. Prophylaxis Picture
    Figure 10. Treatment Picture
    Figure 11. Global Convalescent Plasma Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Convalescent Plasma Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market Convalescent Plasma Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global Convalescent Plasma Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global Convalescent Plasma Therapy Consumption Value Market Share by Region in 2023
    Figure 16. North America Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global Convalescent Plasma Therapy Revenue Share by Players in 2023
    Figure 22. Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players Convalescent Plasma Therapy Market Share in 2023
    Figure 24. Global Top 6 Players Convalescent Plasma Therapy Market Share in 2023
    Figure 25. Global Convalescent Plasma Therapy Consumption Value Share by Type (2019-2024)
    Figure 26. Global Convalescent Plasma Therapy Market Share Forecast by Type (2025-2030)
    Figure 27. Global Convalescent Plasma Therapy Consumption Value Share by Application (2019-2024)
    Figure 28. Global Convalescent Plasma Therapy Market Share Forecast by Application (2025-2030)
    Figure 29. North America Convalescent Plasma Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America Convalescent Plasma Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 31. North America Convalescent Plasma Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe Convalescent Plasma Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe Convalescent Plasma Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 37. Europe Convalescent Plasma Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 39. France Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific Convalescent Plasma Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific Convalescent Plasma Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 45. Asia-Pacific Convalescent Plasma Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 46. China Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 49. India Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America Convalescent Plasma Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America Convalescent Plasma Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 54. South America Convalescent Plasma Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa Convalescent Plasma Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa Convalescent Plasma Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 59. Middle East and Africa Convalescent Plasma Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE Convalescent Plasma Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 63. Convalescent Plasma Therapy Market Drivers
    Figure 64. Convalescent Plasma Therapy Market Restraints
    Figure 65. Convalescent Plasma Therapy Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Convalescent Plasma Therapy in 2023
    Figure 68. Manufacturing Process Analysis of Convalescent Plasma Therapy
    Figure 69. Convalescent Plasma Therapy Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Companies Mentioned

Bio Farma
Grifols
Hilton Pharma
Biotest
BPL
LFB
Octapharma
CSL Behring
Takeda Pharmaceutical Company Limited
Orthosera Kft